Gilead Sciences, Inc. P/B Ratio
Data as of June 01, 2026
P/B Ratio
7.10
Stock Price
$134.43
Book Value/Share
$18.93
Sector
Healthcare
How It's Calculated
7.10 = $134.43 ÷ $18.93
What This Means
Gilead Sciences, Inc.'s P/B ratio of 7.10 is significantly elevated, often seen in asset-light businesses like tech or services where intangible assets drive most of the value.
About Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) operates in the Healthcare sector, specifically in Drug Manufacturers - General. With a market capitalization of about $166.90B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $134.43, within a 52-week range of $104.46 to $157.29 (-14.5% from the high, +28.7% from the low). Beta of 0.33 indicates relatively lower volatility versus the market.
Trailing profit margin is about 31.0%, signaling a strong profit margin relative to many peers.
Understanding This Metric
The price-to-book ratio compares market price to net asset value per share. For Gilead Sciences, Inc., P/B is especially useful when earnings are volatile or temporarily depressed. In Healthcare, asset-heavy business models often anchor closer to book value, while asset-light models may trade far above book.
Sector Comparison
Among Healthcare names on our S&P 100 coverage, Gilead Sciences, Inc.'s P/B ratio of 7.10 can be compared with peers such as LLY (31.65), JNJ (6.68), UNH (3.53). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Healthcare stocks.
Key Takeaways
- GILD is grouped in the Healthcare sector for peer comparisons.
- Recent beta of 0.33 suggests lower-than-market price sensitivity.
- Trailing profit margin of 31.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for GILD.
Other GILD Metrics
Frequently Asked Questions
What does GILD's price-to-book ratio indicate?
P/B compares share price to book value per share. Gilead Sciences, Inc.'s P/B of 7.10 reflects how the market prices net assets — especially relevant for asset-heavy Healthcare business models.
Is 7.10 above or below book value?
A P/B above 1.0 (7.10) means the market values GILD above accounting book value — often due to brands, growth, or intangible assets.
How does P/B compare within Healthcare?
Peer P/B levels in Healthcare (e.g. LLY (31.65), AMGN (19.78), JNJ (6.68)) provide context; asset-light vs asset-heavy models differ materially.
Calculate the p/b ratio for any stock with our free calculator.
Open P/B Ratio Calculator →